• Loading stock data…

Apogee Therapeutics, Inc. Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $483 Million

Last Updated on March 12, 2024 by

[#item_full_content]




Print Friendly, PDF & Email
Spread the word

Reader Interactions

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Discover more from Bio Tech Winners

Subscribe now to keep reading and get access to the full archive.

Continue reading